RxDoctor Payments Data

Ali Maawy, MD

Surgical Oncology · Corpus Christi, TXNPI 1245462852

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (47.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 71.7% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $21,898 and has fallen 86.8% since, to $2,882 in 2025. Among surgical oncology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,902in general payments, 2019–2025

Across 193 payments — averaging $160.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$22K
  • Medical Device Business Services, Inc.$4K
  • Stryker$2K
  • Covidien LP$1K
  • Medtronic$219
  • Johnson & Johnson$189
  • plus $676 from 20 others

What the payments were for

  • Travel & lodging$10,49534%
  • Food & beverage$5,64418%
  • Education$14,75048%
  • Gifts$140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,902 in reported general payments places this provider in the 90th percentile of 191 surgical oncology providers in Texas.

See all surgical oncology providers in Texas

Medicare billing

Part B allowed, 2024
$57,662
Medicare patients
88
Services billed
204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl96$380
Cephalexin57$350
Naproxen59$186
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$167
Celecoxib18$144
Gabapentin27$99
Clindamycin Hcl14$95
Metronidazole20$79
Neomycin Sulfate16$68

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →